ESMO 2026 Guideline: Redefining the Management of Metastatic Colorectal Cancer
oncodaily - Metastatic colorectal cancer (mCRC) represents a complex and biologically diverse disease in which treatment decisions increasingly depend on molecular characteristics, disease burden, and patient-specific factors. While therapeutic options have expanded …
AI Summary: The European Society for Medical Oncology released updated clinical practice guidelines for metastatic colorectal cancer, redefining diagnostic pathways, systemic therapy sequencing, and follow‑up standards. The guidance incorporates recent targeted and immunotherapy evidence to recommend practical treatment algorithms, prompting oncology centers to update protocols and payers to reassess coverage as clinicians translate recommendations into routine care.
Related Stories
Ovarian suppression with tamoxifen cuts recurrence in premenopausal breast cancer / 5 days
Journal retracts study claiming morning immunotherapy benefit / 14 days
Perioperative apalutamide plus ADT improves high‑risk prostate outcomes / 5 wks
Small study reports 100% one‑year survival after lung transplant / 20 hrs
High‑dose targeted radiation shows promise for huge bile duct tumors / 3 months
Nine‑year CheckMate‑214 follow‑up confirms durable immunotherapy benefit / 7 days
Teclistamab shows survival benefit prompting earlier use discussions / 21 days
StackHealth RSS
You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Wildlife, Health Disparities, Olfaction, Research Funding and look for the RSS link.
StackHealth Time Machine